Medicare Enrolled

Dr. Frederic Nguyen, M.D.

Neurology · Richardson, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
2821 E PRESIDENT GEORGE BUSH HWY STE 303, Richardson, TX 75082
2145401400
In practice since 2009 (16 years)
NPI: 1528293628 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nguyen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nguyen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nguyen

Dr. Frederic Nguyen is a neurology in Richardson, TX, with 16 years in practice. Based on federal Medicare data, Dr. Nguyen performed 44,401 Medicare services across 1,208 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nguyen received a total of $343,691 from 79 pharmaceutical and/or device companies across 1155 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nguyen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 2% volume in TX$ $343,691 industry payments

Medicare Practice Summary

Medicare Utilization ↗
44,401
Medicare services
Top 2% in TX for neurology
1,208
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,775 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Capsaicin pain patch (Qutenza)24,761$3$10
Botox injection, per unit14,700$5$20
MRI contrast dye injection (gadoterate)3,140$0$1
Hospital follow-up visit, high complexity290$91$308
Office visit, established patient (30-39 min)278$92$325
Hospital follow-up visit, moderate complexity199$60$213
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes147$181$576
Office visit, established patient, complex (40-54 min)127$126$430
New patient office visit, complex (60-74 min)119$154$592
Office visit, established patient (20-29 min)106$62$224
Needle measurement of electrical activity in arm or leg muscles, limited study82$50$65
Initial hospital admission, high complexity78$133$543
Office visit, established patient (10-19 min)65$40$132
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face63$117$415
Emergency department visit with low level of medical decision making58$53$250
Nerve conduction, 13 or more studies29$229$915
New patient office visit (45-59 min)26$125$468
Mri scan of brain without contrast25$108$1,115
Administration of psychological or neuropsychological test, first 30 minutes19$34$149
Measurement of brain wave activity (eeg), awake and drowsy18$43$169
Initial hospital admission, moderate complexity17$94$411
Mri scan of brain before and after contrast16$163$1,530
Critical care, first 30-74 min16$157$640
Nerve conduction, 9-10 studies11$165$715
Evaluation of neuropsychological test, first hour11$103$424
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$343,691
Total received (2018-2024)
Avg $49,099/year across 7 years
Top 2% in TX for neurology
79
Companies
1,155
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$314,673 (91.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$18,889 (5.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,130 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$98,143
2023
$73,290
2022
$89,749
2021
$67,881
2020
$3,795
2019
$958
2018
$9,875

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$87,203
AbbVie Inc.
$54,107
Otsuka America Pharmaceutical, Inc.
$49,721
ARGENX US, INC.
$26,237
Eisai Inc.
$24,958
Biohaven Pharmaceutical Holding Company Ltd.
$24,119
Corium, LLC
$14,076
PFIZER INC.
$13,292
Biohaven Pharmaceuticals, Inc.
$12,808
EISAI INC.
$9,359
Supernus Pharmaceuticals, Inc.
$8,883
SK Life Science, Inc.
$5,022
UCB, Inc.
$3,566
Allergan, Inc.
$1,484
Acorda Therapeutics, Inc
$571
Teva Pharmaceuticals USA, Inc.
$412
Genentech USA, Inc.
$363
Amgen Inc.
$358
Lundbeck LLC
$354
IMPEL PHARMACEUTICALS INC.
$345
Biogen, Inc.
$333
Novartis Pharmaceuticals Corporation
$330
Horizon Therapeutics plc
$328
Neurocrine Biosciences, Inc.
$327
Alexion Pharmaceuticals, Inc.
$323
ACADIA Pharmaceuticals Inc
$306
Sunovion Pharmaceuticals Inc.
$303
EMD Serono, Inc.
$294
GENZYME CORPORATION
$269
Allergan Inc.
$239
Avanir Pharmaceuticals, Inc.
$228
US WorldMeds, LLC
$211
Upsher-Smith Laboratories LLC
$208
Lilly USA, LLC
$190
Eli Lilly and Company
$175
UPSHER-SMITH LABORATORIES LLC
$146
AstraZeneca Pharmaceuticals LP
$145
MDD US Operations, LLC
$138
Penumbra, Inc.
$119
Sumitomo Pharma America, Inc.
$110
Avion Pharmaceuticals
$107
GE HEALTHCARE
$103
Ipsen Biopharmaceuticals, Inc
$94
Celgene Corporation
$82
TG Therapeutics, Inc.
$74
Neurelis, Inc.
$73
Currax Pharmaceuticals LLC
$73
Abbott Laboratories
$72
Assertio Therapeutics, Inc.
$72
GRT US Holding, Inc.
$71
Grifols USA, LLC
$60
Adamas Pharmaceuticals, Inc.
$59
Arbor Pharmaceuticals, Inc.
$55
Janssen Pharmaceuticals, Inc
$55
Takeda Pharmaceuticals U.S.A., Inc.
$50
CSL Behring
$49
AQUESTIVE THERAPEUTICS, INC.
$49
HOSPIRA, INC.
$44
AbbVie, Inc.
$41
Averitas Pharma Inc.
$39
Medtronic, Inc.
$37
LivaNova USA, Inc.
$31
Mallinckrodt Enterprises LLC
$30
Amneal Pharmaceuticals LLC
$29
Boston Scientific Corporation
$26
Collegium Pharmaceutical, Inc.
$24
Zyla Life Sciences, Inc.
$24
GE HealthCare
$23
SCILEX PHARMACEUTICALS INC.
$21
Kyowa Kirin, Inc.
$20
Bausch Health US, LLC
$19
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
ARBOR PHARMACEUTICALS, INC.
$18
ASSERTIO THERAPEUTICS, Inc.
$17
Almatica Pharma LLC
$16
Life Molecular Imaging Ltd
$16
TerSera Therapeutics LLC
$15
Vertical Pharmaceuticals, LLC
$14
Promius Pharma LLC
$12
Top 3 companies account for 55.6% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · COMIRNATY · COPAXONE · Cambia · DAYBUE · DUOPA · Dhivy · Duopa · Dysport · ELYXYB - celecoxib · EMGALITY · ERGOMAR · Enspryng · Fintepla · Fycompa · GAMMAGARD · GOCOVRI · GRALISE · Gamunex-C · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LATUDA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · PLEGRIDY · Penumbra System · QUDEXY · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RADICAVA · RELEXXII · REXULTI · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · SPRIX · SYMPAZAN · Soliris · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XADAGO · XARELTO · XCOPRI · Xadago · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZIPSOR · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for neurology in TX.

Equivalent to $774 per 100 Medicare services performed
Looking for a neurology in Richardson?
Compare neurologys in the Richardson area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
215
Per 100K population
19.3
County median income
$117,588
Nearest hospital
METHODIST RICHARDSON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nguyen is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 2%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nguyen experienced with capsaicin pain patch (qutenza)?
Based on Medicare claims data, Dr. Nguyen performed 24,761 capsaicin pain patch (qutenza) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nguyen receive payments from pharmaceutical companies?
Yes. Dr. Nguyen received a total of $343,691 from 79 companies across 1,155 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nguyen's costs compare to other neurologys in Richardson?
Dr. Nguyen's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nguyen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →